| Latif Adeyemi Mustapha, NP | |
|
12025 W Apache St, Avondale, AZ 85323-8220 | |
| (623) 241-2084 | |
| Not Available |
| Full Name | Latif Adeyemi Mustapha |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Gerontology |
| Location | 12025 W Apache St, Avondale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700473600 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LG0600X | Nurse Practitioner - Gerontology | 250957 (Arizona) | Primary |
| Entity Name | Arizona Doctors Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033507033 PECOS PAC ID: 8123347325 Enrollment ID: O20150511001806 |
News Archive
Researchers in the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Bioinformatics Institute have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
Moberg Derma AB announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA.
On the occasion of the 2011 Rare Disease Day, EDMA, the European Diagnostic Manufacturers Association, underlines the crucial role the In Vitro Diagnostic industry can play to diagnose rare diseases.
Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.
› Verified 1 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210305000869 |
News Archive
Researchers in the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Bioinformatics Institute have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
Moberg Derma AB announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA.
On the occasion of the 2011 Rare Disease Day, EDMA, the European Diagnostic Manufacturers Association, underlines the crucial role the In Vitro Diagnostic industry can play to diagnose rare diseases.
Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Latif Adeyemi Mustapha, NP 12025 W Apache St, Avondale, AZ 85323-8220 Ph: (623) 241-2084 | Latif Adeyemi Mustapha, NP 12025 W Apache St, Avondale, AZ 85323-8220 Ph: (623) 241-2084 |
News Archive
Researchers in the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Bioinformatics Institute have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.
Idera Pharmaceuticals, Inc. today announced preliminary results from a Phase 1 clinical trial of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for potential applications in autoimmune and inflammatory diseases. In this trial, healthy subjects in five dosage cohorts received single doses of IMO-3100 from 0.04 to 0.64 mg/kg. IMO-3100 was well tolerated at all dose levels.
Moberg Derma AB announced that CE mark has been granted for Kaprolac Skin Repair & Hydration, a product designed to treat atopic eczema and dry skin. This CE mark provides authorization to market and sell the product in the EU/EEA.
On the occasion of the 2011 Rare Disease Day, EDMA, the European Diagnostic Manufacturers Association, underlines the crucial role the In Vitro Diagnostic industry can play to diagnose rare diseases.
Nearly two-thirds of deaths worldwide are caused by non-communicable diseases such as heart and lung disease, cancer, and diabetes, which are increasingly prevalent and cost the global economy trillions of dollars, according to a U.N. report and preliminary results from a new study announced Monday at a press conference to preview the September U.N. High Level Meeting on NCDs, the Associated Press/MSNBC.com reports.
› Verified 1 days ago
Mr. Justin Markel Belford, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3426 N 126th Dr, Avondale, AZ 85392 Phone: 623-695-4011 | |
Courtney Standifird, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10450 W Mcdowell Rd Ste 101, Avondale, AZ 85392 Phone: 623-935-1000 | |
Kia Lambeth, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10815 W Mcdowell Rd Ste 305, Avondale, AZ 85392 Phone: 623-936-3312 Fax: 623-936-4248 | |
Amy Christine Amore, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13075 W Mcdowell Rd Ste D106, Avondale, AZ 85392 Phone: 623-547-0522 | |
Mrs. Marytza Olivas-osuna, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 13055 W Mcdowell Rd Ste G112, Avondale, AZ 85392 Phone: 623-322-5900 | |
Joyce Bour, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12729 W Monte Vista Rd, Avondale, AZ 85392 Phone: 623-792-0209 | |
Bolatito Oyeronke Okougbo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10926 W Ivory Ln, Avondale, AZ 85392 Phone: 623-977-7644 |